A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)
Titel:
A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)
Auteur:
Rothman, Brian Slomkowski, Mary Speier, Austin Rush, A. John Trivedi, Madhukar H. Lakhan, Shaheen E. Lawson, Erica Fahmy, Michael Carpenter, Daniel Chen, Dalei Docherty, John P. Forbes, Ainslie